Top Insider Buys: Medical & Biotech Stocks

by Hisham S. Ayoub, DMD
BioHealth Investor



Following data represents stock purchases by company insiders during the past week. This report may not be accurate or complete, and readers should not base their investment decisions on the following information.



October 8 - October 12

MAP Pharma (MAPP): Oct 11, $12-$14.50 by directors & Perseus Biotech Fund
MEDecision (MEDE): Oct 9-10, $3.10-$3.15 by Marxe Austin & Greenhouse David
MGT Capital Inv (MGT): Oct 8, $3.75 by CEO
MacroChem (MACM): Oct 10, $0.60 by CEO, director & SCO Capital Partners
Gilead Sciences (GILD): Oct 9, $41.84 by CEO



Last Week's Insider Buys Report


To keep up with the latest updates please subscribe:
Subscribe by Feed
Subscribe by Email




BioHealth Investor.com
___________________